These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22095580)

  • 1. Valproic acid in dementia: does an optimal dose exist?
    Dolder CR; Nealy KL; McKinsey J
    J Pharm Pract; 2012 Apr; 25(2):142-50. PubMed ID: 22095580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid for agitation in dementia.
    Lonergan ET; Cameron M; Luxenberg J
    Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose divalproex in agitated patients with Alzheimer's disease.
    Dolder C; McKinsey J
    J Psychiatr Pract; 2010 Jan; 16(1):63-7. PubMed ID: 20098234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder.
    Citrome L
    Int J Clin Pract; 2012 Mar; 66(3):318-25. PubMed ID: 22226343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of anticonvulsants in treating agitated demented elderly patients.
    Grossman F
    Pharmacotherapy; 1998; 18(3):600-6. PubMed ID: 9620110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled study of divalproex sodium for agitation in dementia.
    Porsteinsson AP; Tariot PN; Erb R; Cox C; Smith E; Jakimovich L; Noviasky J; Kowalski N; Holt CJ; Irvine C
    Am J Geriatr Psychiatry; 2001; 9(1):58-66. PubMed ID: 11156753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid treatment of agitation in dementia.
    Herrmann N
    Can J Psychiatry; 1998 Feb; 43(1):69-72. PubMed ID: 9494750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF; Paulsson B; Brecher M
    J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sodium valproate on behavioral disturbances in elderly outpatients with dementia.
    Mizukami K; Hatanaka K; Ishii T; Iwakiri M; Sodeyama N; Tanaka Y; Asada T
    Geriatr Gerontol Int; 2010 Oct; 10(4):324-6. PubMed ID: 20887626
    [No Abstract]   [Full Text] [Related]  

  • 12. The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes--a 12-month follow-up study.
    Selbaek G; Kirkevold Ø; Engedal K
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):528-36. PubMed ID: 18591573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divalproex sodium therapy in elderly with dementia-related agitation.
    Pratt CE; Davis SM
    Ann Pharmacother; 2002 Oct; 36(10):1625-8. PubMed ID: 12243614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia.
    Chibnall JT; Tait RC; Harman B; Luebbert RA
    J Am Geriatr Soc; 2005 Nov; 53(11):1921-9. PubMed ID: 16274373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate in the treatment of behavioral agitation in elderly patients with dementia.
    Lott AD; McElroy SL; Keys MA
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):314-9. PubMed ID: 7580190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.
    Davis R; Peters DH; McTavish D
    Drugs; 1994 Feb; 47(2):332-72. PubMed ID: 7512905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of agitation in older persons with dementia. The Expert Concensus Panel for agitation in dementia.
    Postgrad Med; 1998 Apr; Spec No():1-88. PubMed ID: 9585819
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of intravenous valproic acid for acute migraine.
    Frazee LA; Foraker KC
    Ann Pharmacother; 2008 Mar; 42(3):403-7. PubMed ID: 18303140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium valproate in the treatment of behavioral disturbance in dementia.
    Mellow AM; Solano-Lopez C; Davis S
    J Geriatr Psychiatry Neurol; 1993; 6(4):205-9. PubMed ID: 8251047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
    Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.